Roche Holding Ltd. (VTX:ROG)‘s stock had its “buy” rating restated by stock analysts at JPMorgan Chase & Co. in a research note issued to investors on Monday.
ROG has been the subject of a number of other research reports. Citigroup Inc. reissued a “buy” rating on shares of Roche Holding in a report on Thursday, June 23rd. Goldman Sachs Group Inc. reaffirmed a “buy” rating on shares of Roche Holding in a report on Tuesday, July 19th.
Roche Holding (VTX:ROG) opened at 238.30 on Monday. The stock’s 50 day moving average price is CHK 241.71 and its 200 day moving average price is CHK 245.92. The company has a market cap of CHK 203.07 billion and a PE ratio of 21.85. Roche Holding has a 12-month low of CHK 229.90 and a 12-month high of CHK 281.40.
About Roche Holding
Roche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.